Penumbra Files For IPO On NYSE
Alameda-based Penumbra, which develops medical devices for treating stroke, has filed for a $115M IPO. According to the company, it has applied to list on the New York Stock Exchange as PEN. The IPO is being led by J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities, and Canaccord Genuity. The company is backed by Fidelity.
posted on Monday, August 17, 2015
Related companies:
Penumbra Inc
Related stories:
> Penumbra Buys Controlling Stake In MVI Health
> LinkedIn Selects NYSE For IPO
> Inphi Files For IPO
> Trulia Files For $75M IPO
> Violin Memory Files For IPO
silicontap.com Home